Oragenics EPS OGEN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Oragenics' earnings per share was −$3.58 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.57.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.57	n/a	−$3.58
Q1 FY26	Mar 31, 2026	−$0.51	n/a	−$6.11
Q4 FY25	Dec 31, 2025	−$0.54	n/a	−$9.25
Q3 FY25	Sep 30, 2025	−$1.96	n/a	−$17.11
Q2 FY25	Jun 30, 2025	−$3.10	n/a	−$26.47
Q1 FY25	Mar 31, 2025	−$3.65	n/a	−$38.64
Q4 FY24	Dec 31, 2024	−$8.40	n/a	−$55.99
Q3 FY24	Sep 30, 2024	−$11.32	n/a	−$195.49
Q2 FY24	Jun 30, 2024	−$15.27	n/a	−$209.67
Q1 FY24	Mar 31, 2024	−$21.00	n/a	−$239.70
Q4 FY23	Dec 31, 2023	−$147.90	n/a	−$261.00
Q3 FY23	Sep 30, 2023	−$25.50	n/a	−$143.40

Companies in Healthcare nearest Oragenics' size, closest first, today.

Company	EPS, 12 months	Growth
OGENOragenics	−$3.58
OXBROXBRIDGE RE HOLDINGS	$0.02
EDUCEducational Development	$0.19
GTIMGood Times Restaurants	$0.21	+75% a year
MDRRMedalist Diversified	$3.84
BCGBinah Capital	$0.16
Peer median	$0.19

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.